Medicare Enrolled
Dr. Jeanna Knoble, MD
Hematology & Oncology · Columbus, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Knoble from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Knoble?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Knoble
Dr. Jeanna Knoble is a hematology & oncology specialist in Columbus, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Knoble performed 13,625 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Knoble received a total of $37,599 from 69 pharmaceutical and/or device companies across 305 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Knoble is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 18% volume in OH
$37,599 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗13,625
Medicare services
Top 18% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,340 | $17 | $64 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,852 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,890 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
523 | $7 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 290 | $1 | $41 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
216 | $87 | $390 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $58 | $277 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
175 | $89 | $421 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
108 | $8 | $9 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
94 | $10 | $67 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
91 | $11 | $66 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
89 | $7 | $126 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
82 | $21 | $103 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
73 | $69 | $210 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
54 | $38 | $205 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
50 | $1 | $4 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $127 | $550 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
47 | $52 | $214 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
44 | $5 | $16 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
38 | $37 | $372 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
36 | $143 | $740 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
36 | $26 | $86 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
30 | $44 | $234 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
29 | $43 | $180 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $119 | $509 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
27 | $25 | $121 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
26 | $47 | $208 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
26 | $98 | $406 |
| New patient office visit, complex (60-74 min) | 23 | $158 | $673 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $125 | $595 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
18 | $771 | $4,447 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
15 | $90 | $308 |
| Whole body bone and joint nuclear medicine scan A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body. |
13 | $164 | $725 |
| Technetium Tc-99m medronate diagnostic injection An injection of Technetium Tc-99m medronate used for diagnostic imaging studies. The dose administered is up to 30 millicuries per study. |
13 | $18 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.5% high complexity
87.1% medium
10.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$37,599
Total received (2018-2024)
Avg $5,371/year across 7 years
Top 15% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
305
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,186
2023
$3,510
2022
$4,646
2021
$3,957
2020
$3,711
2019
$6,076
2018
$10,513
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$3,004
PFIZER INC.
$1,571
Janssen Scientific Affairs, LLC
$131
Pharmacosmos Therapeutics Inc.
$58
SpringWorks Therapeutics, Inc.
$48
Incyte Corporation
$42
SERVIER PHARMACEUTICALS LLC
$42
Eisai Inc.
$28
Astellas Pharma US Inc
$26
Alexion Pharmaceuticals, Inc.
$23
Lilly USA, LLC
$22
Regeneron Healthcare Solutions, Inc.
$21
Aveo Pharmaceuticals, Inc.
$20
Genentech USA, Inc.
$20
EMD Serono, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Adaptive Biotechnologies Corporation
$17
Iovance Biotherapeutics, Inc.
$17
Janssen Biotech, Inc.
$16
Amneal Pharmaceuticals LLC
$15
Daiichi Sankyo Inc.
$14
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 90.7% of 2024 payments
All-time payments by company (2018-2024) ›
Puma Biotechnology, Inc.
$6,178
Bayer HealthCare Pharmaceuticals Inc.
$4,945
Daiichi Sankyo Inc.
$3,998
Rigel Pharmaceuticals, Inc.
$3,349
Novartis Pharmaceuticals Corporation
$3,106
Incyte Corporation
$1,718
PFIZER INC.
$1,659
Seattle Genetics, Inc.
$1,624
CTI BioPharma Corp.
$1,476
Seagen Inc.
$1,322
Veracyte, Inc.
$994
Janssen Biotech, Inc.
$858
Spectrum Pharmaceuticals Inc.
$750
E.R. Squibb & Sons, L.L.C.
$657
Takeda Pharmaceuticals U.S.A., Inc.
$348
Amgen Inc.
$315
Eisai Inc.
$277
AstraZeneca Pharmaceuticals LP
$262
Heron Therapeutics, Inc.
$240
Celgene Corporation
$180
Pharmacyclics LLC, An AbbVie Company
$175
Exelixis Inc.
$174
Dova Pharmaceuticals
$166
EMD Serono, Inc.
$151
Mirati Therapeutics, Inc.
$145
Sirtex Medical Inc
$142
GENZYME CORPORATION
$135
Flowonix Medical Incorporated
$134
EISAI INC.
$133
Janssen Scientific Affairs, LLC
$131
Regeneron Pharmaceuticals, Inc.
$129
Genentech USA, Inc.
$116
Ipsen Biopharmaceuticals, Inc
$108
Taiho Oncology, Inc.
$94
Merck Sharp & Dohme LLC
$81
ARRAY BIOPHARMA INC
$79
Astellas Pharma US Inc
$77
Pharmacosmos Therapeutics Inc.
$71
Regeneron Healthcare Solutions, Inc.
$71
Karyopharm Therapeutics Inc.
$65
Agios Pharmaceuticals, Inc.
$64
SERVIER PHARMACEUTICALS LLC
$64
GlaxoSmithKline, LLC.
$63
Lilly USA, LLC
$58
Pharmacyclics LLC, an AbbVie Company
$53
SpringWorks Therapeutics, Inc.
$48
Coherus Biosciences Inc.
$46
JAZZ PHARMACEUTICALS INC.
$45
ADC Therapeutics America, Inc.
$42
Gilead Sciences, Inc.
$42
Aveo Pharmaceuticals, Inc.
$42
AVEO Pharmaceuticals, Inc.
$40
AMAG Pharmaceuticals, Inc.
$35
Acceleron Pharma, Inc.
$33
Kite Pharma, Inc.
$27
Foundation Medicine, Inc.
$27
Alexion Pharmaceuticals, Inc.
$23
Sun Pharmaceutical Industries Inc.
$22
PharmaEssentia USA Corporation
$21
TAIHO ONCOLOGY, INC.
$20
BeiGene USA, Inc.
$19
Blueprint Medicines Corporation
$18
TESARO, Inc.
$17
Adaptive Biotechnologies Corporation
$17
SOBI, INC
$17
Iovance Biotherapeutics, Inc.
$17
Merck Sharp & Dohme Corporation
$15
Secura Bio, Inc.
$15
Amneal Pharmaceuticals LLC
$15
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AVASTIN · AYVAKIT · Abraxane · Aliqopa · Amtagvi · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · COSELA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · EMPLICITI · ENHERTU · ERLEADA · EXKIVITY · Enhertu · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · GAZYVA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INQOVI · Imbruvica · JAKAFI · JAYPIRCA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LYNPARZA · Lenvima · Lonsurf · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · OGSIVEO · OPDIVO · PADCEV · PLUVICTO · Padcev · Perjeta · Pomalyst · Prometra II · REBLOZYL · ROLVEDON · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · TAGRISSO · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tibsovo · ULTOMIRIS · Udenyca · VERZENIO · VPRIV · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XPOVIO · Xofigo · Xtandi · YONSA · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
54
County median income
$73,795
Nearest hospital to ZIP centroid (approximate)
RIVER VISTA HEALTH AND WELLNESS LLC
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Knoble is a mixed practice specialist, with above-average Medicare volume (top 18% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Knoble experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Knoble performed 5,340 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Knoble receive payments from pharmaceutical companies?
Yes. Dr. Knoble received a total of $37,599 from 69 companies across 305 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Knoble's costs compare to other hematology & oncology specialists in Columbus?
Dr. Knoble's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Knoble) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Columbus
Browse hematology & oncology specialists in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology